Clinical Trials Logo

Clinical Trial Summary

This is the second phase of a two-part study. In the first phase (Protocol ID: R34AT009170), the investigators refined and piloted the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and to living with chronic disease. In this part of the study, the investigators will use data from the first phase to further adapt the intervention manual, and test the final product via a small randomized controlled trial in the same population.


Clinical Trial Description

Overview. This is the second phase of a two-part study. In the first phase (Protocol ID: R34AT009170), the investigators adapted an existing resiliency intervention, the Relaxation Response Resiliency Program (3RP), to the needs of women ages 50 and over who are living with HIV. The investigators conducted preliminary testing of the refined group intervention via an open pilot study (N=13 enrolled) across two sites, MGH and Boston Medical Center), and conducted individual exit interviews to solicit feedback on the intervention. Based on these qualitative data, as well as qualitative work conducted previously with this population, the goal of this phase of the project is to conduct a small, randomized pilot of the intervention in groups of up to 10 women with HIV (total N=up to 60) to assess feasibility and acceptability of all study procedures. Study Procedures. Participants will be women living with HIV (N=up to 60) age 50 or over, who are recruited via flyers and provider referral from Boston area hospitals and health care settings, as well as community organizations serving individuals living with HIV. Once an individual expresses interest in the study, they will be screened by a study staff member, either by phone or in person, in order to assess study eligibility. Eligible and interested individuals will be invited to sign informed consent and complete an in-person baseline assessment. Participants will be randomized to either a 10-week intervention group (adapted 3RP intervention) or a 10-week control group (supportive psychotherapy program). Participants will then complete a post-treatment assessment, an individual in-depth exit interview to provide feedback on their experience in the study, and a 3-month follow-up assessment. Data from this second phase of the study will inform the eventual development of a full-scale randomized controlled trial. Adapted 3RP Intervention. Once randomized into the intervention condition, participants will complete 10, 90-minute weekly group sessions of the adapted 3RP intervention. Sessions will focus on developing an understanding of stress sources and physiology, and on developing a regular practice of eliciting the relaxation response (RR) and learning cognitive behavioral and positive psychology skills to enhance resiliency to long-term stress. Participants will be encouraged to practice skills (RR practice, thoughts records to learn adaptive thinking) between group sessions. Supportive Psychotherapy Control Program. The control condition will be a supportive therapy program that is matched to the intervention for number and length of sessions. Basic principles of supportive psychotherapy will be followed, and the interventionist will facilitate discussion around what it is like to live with HIV as an aging woman. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03673098
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase N/A
Start date November 5, 2018
Completion date April 14, 2021

See also
  Status Clinical Trial Phase
Completed NCT03270943 - The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens N/A
Terminated NCT04970641 - Three Good Things (3GT) - Intervention for Transitional Care Patients N/A
Completed NCT03308981 - Efficacy of the REThink Therapeutic Online Game N/A
Not yet recruiting NCT06061965 - Facilitating Advance Care Planning Discussions for People With Advance Cancer N/A
Active, not recruiting NCT05293431 - Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic N/A
Recruiting NCT05072340 - Evaluation of Resilience Skills Enhancement (RISE) Training Among University Students N/A
Recruiting NCT05094115 - Enhancing Resiliency and Optimizing Readiness in Military Personnel N/A
Active, not recruiting NCT05719129 - The Lasting Change Study
Completed NCT03071887 - Resilience Intervention for Older, HIV-Infected Women N/A
Recruiting NCT05130879 - Building Resilience @ Work Training Among Healthcare Workers N/A
Active, not recruiting NCT03705208 - Youth First: A Longitudinal Impact Evaluation N/A
Completed NCT05703529 - Group-based Positive Psychotherapy in Psychological Resilience of Only-Child-Lost People N/A
Completed NCT02603133 - Web-based Implementation for the Science of Enhancing Resilience Study N/A
Completed NCT05133115 - Fostering Resilience in Adolescents at Risk. N/A
Recruiting NCT04935710 - Prevention and Early Identification for High Risk Youth in School-based Clinics Phase 1
Completed NCT04231604 - Evaluation of a School-based Programme Aimed at Promoting Well-being in Adolescents N/A
Enrolling by invitation NCT06021236 - Efficacy of a Mindfulness-Based Intervention in Patients With Cardiovascular Implantable Electronic Device N/A
Active, not recruiting NCT05648045 - Resilience and Obesity Prevention in Adolescents
Recruiting NCT03458936 - Resilience in Adolescent Development
Completed NCT05154565 - Effect of a Daily Meditation Intervention in Student Pharmacists N/A